You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Famotidine, Calcium Carbonate, And Magnesium Hydroxide patents expire, and when can generic versions of Famotidine, Calcium Carbonate, And Magnesium Hydroxide launch?

Famotidine, Calcium Carbonate, And Magnesium Hydroxide is a drug marketed by Perrigo R And D and is included in two NDAs.

The generic ingredient in FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
  • What are the global sales for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
  • What is Average Wholesale Price for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
Summary for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
Drug patent expirations by year for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE

US Patents and Regulatory Information for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 077355-001 Feb 6, 2008 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo R And D FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 204782-001 Aug 29, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.